Neptune Technologies & Bioressources Inc  

(Public, TSE:NTB)   Watch this stock  
Find more results for NTB
2.11
0.00 (0.00%)
Mar 30 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 2.07 - 2.11
52 week 1.26 - 3.15
Open 2.10
Vol / Avg. 7,721.00/30,560.00
Mkt cap 158.21M
P/E     -
Div/yield     -
EPS -0.25
Shares 74.98M
Beta 1.80
Inst. own     -
May 19, 2015
Q4 2015 Neptune Technologies & Bioressources Inc Earnings Release (Estimated) Add to calendar
Mar 10, 2015
Neptune Technologies & Bioressources Inc at ROTH Conference
Jan 14, 2015
Q3 2015 Neptune Technologies & Bioressources Inc Earnings Call
Jan 13, 2015
Neptune Technologies & Bioressources Inc at OneMedForum SF
Jan 13, 2015
Q3 2015 Neptune Technologies & Bioressources Inc Earnings Release
  

Key stats and ratios

Q4 (Nov '14) 2014
Net profit margin 1.56% -114.06%
Operating margin -123.13% -112.41%
EBITD margin - -103.69%
Return on average assets 0.26% -26.21%
Return on average equity -7.96% -31.30%
Employees 111 -
CDP Score - -

Address

545 Prom du Centropolis Suite 100
LAVAL, QC H7T 0A3
Canada
+1-450-6872262 (Phone)
+1-450-6872272 (Fax)

Website links

Description

Neptune Technologies & Bioressources Inc. (Neptune) is a Canada-based biotechnology company. The Company is engaged primarily in the development, manufacture and commercialization of marine-derived omega-3 polyunsaturated fatty acids (PUFAs). The Company operates in three segments: Neptune, Acasti Pharma Inc. and NeuroBioPharmInc. The Neptune segment produces and commercializes nutraceutical products. The Company�s Acasti Pharma Inc. develops and commercializes pharmaceutical applications for cardiovascular diseases. The Company�s NeuroBioPharm Inc. develops and commercializes pharmaceutical applications for neurological diseases. The Company�s products include Neptune Krill Oil (NKO) and ECOKRILL Oil (EKO) which come in capsule form and serve as a dietary supplement to consumers.

Officers and directors

Pierre Fitzgibbon Chairman of the Board
Age: 60
James Stuart Hamilton President, Chief Executive Officer, Director
Andre Godin Chief Financial Officer
Michel Timperio Senior Vice President of Sales - Global Sales
Wael Massrieh Vice President - Scientific Affairs
Fotini Sampalis M.D., Ph.D. Chief Global Strategy Officer
Ronald Denis Director
Harlan W. Waksal M.D. Director
Age: 60
Valier Boivin Independent Director
Adrian Montgomery Independent Director